Medexus Pharma Canada

Delivering Innovative Products to the Canadian Market

Medexus Pharma Canada is a Canadian-based specialty pharmaceutical company focused on the key areas of rheumatology, auto-immune disease, pediatrics, allergy, and dermatology. The company manages the licensing, registration, marketing, sales, and distribution of several innovative pharmaceutical products in Canada.

Medexus Pharma Canada leverages its extensive market knowledge and strong Canadian position as an innovator with new and existing products to deliver clinically proven safe and effective brands and consistent product value.

As part of its commitment to continued growth in current and new therapeutic areas, the company fosters many unique relationships with customers and healthcare professionals, as well as with key partners around the globe.

Pediapharm, Inc.

Pediapharm, a division of Medexus Pharma Canada, distributes and licenses innovative prescription medicines used to treat pathological conditions that primarily affect the pediatric community.

By partnering with leading healthcare entities around the world, Pediapharm continues to bring innovative products to the Canadian market and improve the health and the well-being of the Canadian children and adult population.

About Medexus

About Medexus

Medexus Pharmaceuticals, Inc. is a leading specialty pharmaceutical company based in North America that focuses on the therapeutic areas of rheumatology, auto-immune disease, specialty oncology and pediatric diseases.

About Us
Rasuvo®
Metoject®
Rupall™
Gliolan®
Treosulfan

Product Portfolio

Our highly diversified product portfolio and growing pipeline features several leading products such as Rasuvo, Metoject, Rupall, Treosulfan, and Gliolan.

View Product Portfolio